Cubis®High-Capacity Micro Balances: Weigh Minimum Amounts of Sample Directly into Heavy Flasks

Cubis®High-Capacity Micro Balances: Weigh Minimum Amounts of Sample Directly into Heavy Flasks

Pharmaceutical Industries

January 17, 2018

No More Wasting Expensive Samples: Accurately Weigh Small Amounts

The new Cubis® micro balance enables an extremely low sample weight, allowing you to comply with USP and FDA requirements. You can manage with significantly reduced quantities of your samples, which may be costly or only available in small amounts.


Save Costs by Eliminating the Need for Using Weigh Boats and Paper

Since challenging sample transfer is no longer required, you will not only save time, but also the cost of purchasing weigh boats and paper, as well as the expense of subsequent disposal.

A unique Cubis® individual software

Q-Apps are application programs that guide you step by step through a workflow, without the need for running these apps using a laptop or middleware, they are directly downloaded to the high-capacity Cubis® microbalance with the unique Cubis® individual software.


Automated Preparation of Standard Solutions

The Dosing Q-App automatically adjusts the volume of the solvent to the weight of your compound and determines the verified final concentration of your standard solution based on the weight of the solvent actually added. Time-consuming and error-prone manual preparation of standards using volumetric determination is now a thing of the past.

VitaFast Vitamin C (L-Ascorbic Acid)

VitaFast Vitamin C (L-Ascorbic Acid)

Pharmaceutical Industries

VitaFast Vitamin C (L-Ascorbic Acid) is an enzymatic test in microtiter plate format for the quantitative determination of vitamin C (L-ascorbic acid) in food, pharmaceutical products and other sample materials.

August 01, 2013 More +
Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Pharmaceutical Industries

Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.

October 22, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us